To exclude smaller risks (i.e., a larger NNH) and to aside concerns regarding the influence of longer duration of medication exposition and the outcome, further evidence is needed
Whatever your views on the broader social merits of these medications, theres something deeply incongruent about their use in a domain that purports to celebrate the unaided limits of human performance
Anahita Dua, director of the Vascular Lab at Harvard-affiliated Massachusetts General Hospital
However, it should be noted that a recent international consensus document to define renal progression outcomes indicates decreases of 30, 40, 50 or 57% of kidney function as possible surrogates for progression, depending on factors such as the rate of progression, the choice of initial eGFR starting point or the effect of interventions with acute consequences on eGFR.39 4
The expression of GLP-1 has been seen to spike following gastric bypass surgery and this increase in GLP-1 levels is thought to play a role in appetite suppression and is responsible for postsurgical weight loss and improvements in glucose metabolism [19]